Envafolimab Combined With Chemotherapy in Metastatic or Recurrent Gastric Adenocarcinoma
Status:
Not yet recruiting
Trial end date:
2024-03-01
Target enrollment:
Participant gender:
Summary
The objective is to investigate the efficacy and safety of Envafolimab combined with
chemotherapy in the treatment of metastatic or recurrent gastric adenocarcinoma.